JAK1 and neoplasm: The increased immune cell infiltrate was less pronounced in MHC-deficient HCmel12 Jak1-KO tumours when compared to HCmel12 CRISPR-ctrl tumours, in line with our observation in patient samples (Fig. 1a and Extended Data Fig. 1a,b).